Quote:

---

It just seems like this hold has gone from "What did you do and how did you do it/" to "What are you planning to do and how and you going to do it?"

---

It does seem that way. So why are they asking about protocol? It seems to me that there are only two factors that could change the safety of a drug that's been safe: 1) length of the trial and 2) dosage.

Since some patients have been taking Leron safely for numerous years, the length of a trial could not be a problem.

So the protocol of upcoming tests shouldn't be a question of safety in any way, unless CYDY is planning a trial with a much higher dosage. Assuming the HIV trials to come aren't using a bigger dose, I don't see what the FDA is in truth asking about. Unless it's dicking with us. Government agencies aren't supposed to dick.